CliffBio

Sarepta Therapeutics

Patent cliffs & loss of exclusivity

Sarepta Therapeutics is a biotechnology company developing precision genetic medicines for rare diseases, including RNA-targeted therapies and gene therapies.

Company

Also Known AsSarepta Therapeutics INC Sarepta Therapeutics
AngelList URLhttps://angel.co/sarepta-therapeutics
Legal NameSarepta Therapeutics, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.sarepta.com/about-us/contact-us
Crunchbase URLhttps://www.crunchbase.com/organization/sarepta-therapeutics#section-ipo-stock-price
Email format{f}{last}
Facebook URLhttps://www.facebook.com/Sarepta-Therapeutics-208950446535427/

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. VYONDYS 53GOLODIRSENSmall mol.Jun 2028
  2. AMONDYS 45CASIMERSENSmall mol.Nov 2030
  3. EXONDYS 51ETEPLIRSENSmall mol.Mar 2034
  4. EXONDYS 51ETEPLIRSENSmall mol.Mar 2034
  5. ELEVIDYSdelandistrogene moxeparvovec-roklBiologicJun 2035

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.